Literature DB >> 20703890

The validity and reliability of the Turkish version of the Revised Fibromyalgia Impact Questionnaire.

Levent Ediz1, Ozcan Hiz, Murat Toprak, Ibrahım Tekeoglu, Songul Ercan.   

Abstract

The Revised Fibromyalgia Impact Questionnaire (FIQR) attempts to address the limitations of the Fibromyalgia Impact Questionnaire (FIQ). As there is no Turkish version of the FIQR available, we aimed to investigate the validity and reliability of a Turkish translation of the FIQR in Turkish female fibromyalgia (FM) patients. After translating the FIQR into Turkish, it was administered to 87 female patients with FM. All of the patients filled out the questionnaire together with a Turkish version of the FIQ, hospital anxiety and depression scales (HADS), short form-36 (SF-36). The tender-point count (TPC) was also calculated from tender points identified by thumb palpation. One week later, FM patients filled out the Turkish FIQR at their second visit. The test-retest reliability of the Turkish FIQR questions ranged from 0.714 to 0.898. The test and retest reliability of total FIQR score was 0.835. Cronbach's alpha was 0.89 for FIQR visit 1 (the first assessment) and 0.91 for FIQR visit 2 (the second assessment), indicating acceptable levels of internal consistency for both assessments. The total scores of the FIQR and FIQ were significantly correlated (r = 0.87, P < 0.01). Significant correlations for construct validity were also obtained between the FIQR total and domain scores and the FIQ, the HADS and the subscales of the SF-36 (FIQR total versus SF-36 physical component score and mental component score were r = -0.63, P < 0.01 and r = -0.51, P < 0.01, respectively). The Turkish FIQR is a reliable and valid instrument for measuring health status in FM, showing sufficient reliability and construct validity. It may be utilized for both clinical practice and research use in the Turkish-speaking population in place of FIQ, since its Turkish version has problems in the wording, omissions, concepts, and scoring from the original FIQ.

Entities:  

Mesh:

Year:  2010        PMID: 20703890     DOI: 10.1007/s10067-010-1546-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Reliability and construct validity of the SF-36 in Turkish cancer patients.

Authors:  Rukiye Pinar
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

Review 2.  Are the contents of treatment outcomes in fibromyalgia trials represented in the International Classification Of Functioning, Disability, and Health?

Authors:  Martin Offenbächer; Alarcos Cieza; Thomas Brockow; Edda Amann; Barbara Kollerits; Gerold Stucki
Journal:  Clin J Pain       Date:  2007-10       Impact factor: 3.442

3.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

Authors:  R Bennett
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

4.  The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario.

Authors:  K P White; M Speechley; M Harth; T Ostbye
Journal:  J Rheumatol       Date:  1999-07       Impact factor: 4.666

Review 5.  Assessment instruments for patients with fibromyalgia: properties, applications and interpretation.

Authors:  F Salaffi; P Sarzi-Puttini; A Ciapetti; F Atzeni
Journal:  Clin Exp Rheumatol       Date:  2009 Sep-Oct       Impact factor: 4.473

6.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

7.  The fibromyalgia impact questionnaire: development and validation.

Authors:  C S Burckhardt; S R Clark; R M Bennett
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666

Review 8.  Treatment strategy in fibromyalgia syndrome: where are we now?

Authors:  Piercarlo Sarzi-Puttini; Dan Buskila; Mario Carrabba; Andrea Doria; Fabiola Atzeni
Journal:  Semin Arthritis Rheum       Date:  2007-10-31       Impact factor: 5.532

Review 9.  EULAR evidence-based recommendations for the management of fibromyalgia syndrome.

Authors:  S F Carville; L Arendt-Nielsen; S Arendt-Nielsen; H Bliddal; F Blotman; J C Branco; D Buskila; J A P Da Silva; B Danneskiold-Samsøe; F Dincer; C Henriksson; K G Henriksson; E Kosek; K Longley; G M McCarthy; S Perrot; M Puszczewicz; P Sarzi-Puttini; A Silman; M Späth; E H Choy
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

10.  An internet survey of 2,596 people with fibromyalgia.

Authors:  Robert M Bennett; Jessie Jones; Dennis C Turk; I Jon Russell; Lynne Matallana
Journal:  BMC Musculoskelet Disord       Date:  2007-03-09       Impact factor: 2.362

View more
  12 in total

1.  Effects of Vitamin D Therapy on Quality of Life in Patients with Fibromyalgia.

Authors:  Atalay Dogru; Ayse Balkarli; Veli Cobankara; Sevket Ercan Tunc; Mehmet Sahin
Journal:  Eurasian J Med       Date:  2017-06

2.  The prevalence of fibromyalgia in patients with Behçet's disease and its relation with disease activity.

Authors:  Mehmet Melikoglu; Meltem Alkan Melikoglu
Journal:  Rheumatol Int       Date:  2012-09-28       Impact factor: 2.631

3.  The validity and reliability of the Persian version of the Revised Fibromyalgia Impact Questionnaire.

Authors:  Banafsheh Ghavidel Parsa; Alireza Amir Maafi; Afrooz Haghdoost; Yasaman Arabi; Monire Khojamli; Gelayol Chatrnour; Ali Bidari
Journal:  Rheumatol Int       Date:  2014-01-01       Impact factor: 2.631

4.  The validity and reliability of the Moroccan version of the Revised Fibromyalgia Impact Questionnaire.

Authors:  Najlaa Srifi; Rachid Bahiri; Samira Rostom; Imad Bendeddouche; Noufissa Lazrek; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2013-01       Impact factor: 2.631

5.  Validation of the Arabic version of the revised Fibromyalgia Impact Questionnaire (FIQR_A) on Jordanian females with fibromyalgia.

Authors:  Sana Abu-Dahab; Salah M AbuRuz; Khader Mustafa; Yusef Sarhan
Journal:  Clin Rheumatol       Date:  2013-07-31       Impact factor: 2.980

6.  Effectiveness of peripheral nerve blockage on the symptoms of both diseases in patients with fibromyalgia and chronic migraine coexistence.

Authors:  Gokhan Evcili; Ahmet Yabalak
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-08       Impact factor: 1.712

7.  A Brazilian Portuguese version of the Revised Fibromyalgia Impact Questionnaire (FIQR): a validation study.

Authors:  Eduardo S Paiva; Roberto E Heymann; Marcelo C Rezende; Milton Helfenstein; Jose Eduardo Martinez; Jose Roberto Provenza; Aline Ranzolin; Marcos Renato de Assis; Vivian D Pasqualin; Robert M Bennett
Journal:  Clin Rheumatol       Date:  2013-04-21       Impact factor: 2.980

8.  Not throwing out the baby with the bathwater: lessons from the Fibromyalgia Impact Questionnaire.

Authors:  C Paul van Wilgen; Pieter Jelle Vuijk; Miriam W van Ittersum; Jo Nijs
Journal:  Clin Rheumatol       Date:  2012-11-30       Impact factor: 2.980

9.  Postural control deficits in people with fibromyalgia: a pilot study.

Authors:  Kim D Jones; Laurie A King; Scott D Mist; Robert M Bennett; Fay B Horak
Journal:  Arthritis Res Ther       Date:  2011-08-02       Impact factor: 5.156

10.  Validation of a Spanish version of the Revised Fibromyalgia Impact Questionnaire (FIQR).

Authors:  Monika Salgueiro; Juan Miguel García-Leiva; Javier Ballesteros; Javier Hidalgo; Rocío Molina; Elena P Calandre
Journal:  Health Qual Life Outcomes       Date:  2013-08-01       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.